Credit Suisse’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-26,970
| Closed | -$326K | – | 3124 |
|
|
2023
Q3 | $326K | Sell |
26,970
-951
| -3% | -$11.5K | ﹤0.01% | 2895 |
|
|
2023
Q2 | $295K | Buy |
27,921
+5,698
| +26% | +$60.3K | ﹤0.01% | 2994 |
|
|
2023
Q1 | $219K | Buy |
22,223
+930
| +4% | +$9.15K | ﹤0.01% | 3072 |
|
|
2022
Q4 | $313K | Buy |
21,293
+6,873
| +48% | +$101K | ﹤0.01% | 2998 |
|
|
2022
Q3 | $176K | Buy |
14,420
+8
| +0.1% | +$98 | ﹤0.01% | 3275 |
|
|
2022
Q2 | $202K | Buy |
14,412
+2,203
| +18% | +$30.9K | ﹤0.01% | 3306 |
|
|
2022
Q1 | $175K | Buy |
+12,209
| New | +$175K | ﹤0.01% | 3384 |
|
|
2021
Q3 | – | Sell |
-6,454
| Closed | -$201K | – | 3573 |
|
|
2021
Q2 | $201K | Sell |
6,454
-2,062
| -24% | -$64.2K | ﹤0.01% | 3430 |
|
|
2021
Q1 | $261K | Buy |
+8,516
| New | +$261K | ﹤0.01% | 3194 |
|